Documentos clave

Ver Toda la documentación

Saltar a

1643452

USP

Terazosin hydrochloride

Name: Terazosin hydrochloride
Brand: USP

United States Pharmacopeia (USP) Reference Standard

Sinónimos:

Terazosin hydrochloride dihydrate, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride dihydrate

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas

Talla/SKU	Disponibilidad	Precio

Acerca de este artículo

Fórmula empírica (notación de Hill):

C₁₉H₂₅N₅O₄ · HCl · 2H₂O

Número CAS:

70024-40-7

Peso molecular:

459.92

NACRES:

NA.24

PubChem Substance ID:

329751228

UNSPSC Code:

41116107

MDL number:

MFCD00941408

eCl@ss:

25140904

En este momento no podemos mostrarle ni los precios ni la disponibilidad

Servicio técnico

¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.

Permítanos ayudarle

Propiedades

grade

pharmaceutical primary standard

agency

USP

API family

terazosin

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)
pharmaceutical

format

neat

SMILES string

O.O.Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4

InChI

1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2

InChI key

NZMOFYDMGFQZLS-UHFFFAOYSA-N

Gene Information

human ... ADRA1A(148), ADRA1B(147), ADRA1D(146)

Descripción

General description

Find answers to frequently asked questions on USP products in USP FAQs.

Terazosin hydrochloride is a quinazoline derivative. It is a alpha-1-selective adrenoceptor blocking agent. It has been used to treat hypertension, as it helps the blood vessels to relax, expand and improves blood flow.

Application

Terazosin hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

Terazosin Capsules
Terazosin Tablets

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo	PHR1721	Y0000621	Y0002286
USP 1643452 Terazosin hydrochloride	Supelco PHR1721 Terazosin Hydrochloride	Y0000621 Terazosin hydrochloride dihydrate	Y0002286 Terazosin for system suitability A
description United States Pharmacopeia (USP) Reference Standard	description Pharmaceutical Secondary Standard; Certified Reference Material	description European Pharmacopoeia (EP) Reference Standard	description European Pharmacopoeia (EP) Reference Standard
grade pharmaceutical primary standard	grade pharmaceutical secondary standard, certified reference material	grade pharmaceutical primary standard	grade pharmaceutical primary standard
manufacturer/tradename USP	manufacturer/tradename -	manufacturer/tradename EDQM	manufacturer/tradename EDQM
application(s) pharmaceutical (small molecule) pharmaceutical	application(s) pharmaceutical pharmaceutical (small molecule) pharmaceutical	application(s) pharmaceutical (small molecule) pharmaceutical	application(s) -
format neat	format neat	format neat	format -
agency USP	agency traceable to USP 1643452, traceable to Ph. Eur. Y0000621	agency -	agency BP
Gene Information human ... ADRA1A(148), ADRA1B(147), ADRA1D(146)	Gene Information human ... ADRA1A(148), ADRA1B(147), ADRA1D(146)	Gene Information human ... ADRA1A(148), ADRA1B(147), ADRA1D(146)	Gene Information -

Still not finding the right product?

Explore all of our products under Terazosin hydrochloride

Pictogramas

GHS07

Palabra de advertencia

Warning

Códigos de peligro

H319

Indicaciones de precaución

P264 - P280 - P305 + P351 + P338 - P337 + P313

Hazard Classifications

Eye Irrit. 2

Clase de almacenamiento

11 - Combustible Solids

Punto de inflamación (°F)

Not applicable

Punto de inflamación (°C)